DK149091C - Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number
DK149091C
DK149091C DK109180A DK109180A DK149091C DK 149091 C DK149091 C DK 149091C DK 109180 A DK109180 A DK 109180A DK 109180 A DK109180 A DK 109180A DK 149091 C DK149091 C DK 149091C
Authority
DK
Denmark
Prior art keywords
ubiquitin
desaminodipeptides
peptids
analogue
amides
Prior art date
Application number
DK109180A
Other languages
Danish (da)
English (en)
Other versions
DK149091B (da
DK109180A (da
Inventor
Gideon Goldstein
George Heavner
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of DK109180A publication Critical patent/DK109180A/da
Publication of DK149091B publication Critical patent/DK149091B/da
Application granted granted Critical
Publication of DK149091C publication Critical patent/DK149091C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/66—Thymopoietins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK109180A 1979-03-14 1980-03-13 Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf DK149091C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2015779 1979-03-14
US06/020,157 US4215111A (en) 1979-03-14 1979-03-14 Peptides having ubiquitin-like activity

Publications (3)

Publication Number Publication Date
DK109180A DK109180A (da) 1980-09-15
DK149091B DK149091B (da) 1986-01-20
DK149091C true DK149091C (da) 1986-06-16

Family

ID=21797065

Family Applications (1)

Application Number Title Priority Date Filing Date
DK109180A DK149091C (da) 1979-03-14 1980-03-13 Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (18)

Country Link
US (1) US4215111A (de)
EP (1) EP0016612B1 (de)
JP (1) JPS55143946A (de)
AT (1) ATE1856T1 (de)
AU (1) AU544923B2 (de)
CA (1) CA1146166A (de)
DE (1) DE3061127D1 (de)
DK (1) DK149091C (de)
ES (1) ES8103026A1 (de)
FI (1) FI67691C (de)
GR (1) GR68038B (de)
IE (1) IE49423B1 (de)
IL (1) IL59603A (de)
NO (1) NO149998C (de)
NZ (1) NZ193077A (de)
PT (1) PT70948B (de)
YU (1) YU41913B (de)
ZA (1) ZA801483B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369137A (en) * 1980-06-17 1983-01-18 Ortho Pharmaceutical Corporation N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide
US4298523A (en) * 1980-06-17 1981-11-03 Ortho Pharmaceutical Corporation Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
US4289759A (en) * 1980-06-23 1981-09-15 Ortho Pharmaceutical Corporation Immunoregulatory diketopiperazine compounds
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
WO1986004334A1 (en) * 1985-01-18 1986-07-31 MERCK Patent Gesellschaft mit beschränkter Haftung Immunoregulatory peptides
JPH01104193A (ja) * 1986-06-10 1989-04-21 Kyowa Hakko Kogyo Co Ltd 新規ポリペプチド
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
AU6770794A (en) * 1993-04-23 1994-11-21 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US5770720A (en) * 1995-08-30 1998-06-23 Barnes-Jewish Hospital Ubiquitin conjugating enzymes having transcriptional repressor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113858A (en) * 1975-01-20 1978-09-12 St. Luke's Hospital Novel compounds, compositions and methods of their use
FR2391994A1 (fr) * 1977-05-25 1978-12-22 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese
SE446866B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en aktiv polypeptid med formaga att inducera differentiering av bade t-lymfocyter och komplementreceptor (cr?72+) b-lymfocyter
SE446867B (sv) * 1977-11-15 1986-10-13 Sloan Kettering Inst Cancer Sett att framstella en polypeptid med formaga att inducera differentiering av t-lymfocyter men inte av komplementreceptor (cr?72+) b-lymfocyter
NZ189101A (en) * 1977-12-08 1984-07-06 Ortho Pharma Corp Polypeptides having the ability to induce differentiation of both th-1+ t-lymphocytes and bu-1+ b-lymphocytes;pharmaceutical compositions

Also Published As

Publication number Publication date
NO149998C (no) 1984-08-01
IE800515L (en) 1980-09-14
IE49423B1 (en) 1985-10-02
CA1146166A (en) 1983-05-10
JPS55143946A (en) 1980-11-10
YU65980A (en) 1984-02-29
ATE1856T1 (de) 1982-12-15
NO149998B (no) 1984-04-24
ES489521A0 (es) 1981-02-16
AU544923B2 (en) 1985-06-20
NO800724L (no) 1980-09-15
US4215111A (en) 1980-07-29
FI67691C (fi) 1985-05-10
ES8103026A1 (es) 1981-02-16
EP0016612B1 (de) 1982-11-24
FI800779A (fi) 1980-09-15
IL59603A (en) 1983-02-23
EP0016612A2 (de) 1980-10-01
YU41913B (en) 1988-02-29
PT70948A (en) 1980-04-01
AU5631380A (en) 1980-09-18
FI67691B (fi) 1985-01-31
GR68038B (de) 1981-10-27
DK149091B (da) 1986-01-20
JPH0153268B2 (de) 1989-11-13
ZA801483B (en) 1981-10-28
EP0016612A3 (en) 1981-01-07
DK109180A (da) 1980-09-15
DE3061127D1 (en) 1982-12-30
PT70948B (en) 1981-06-24
IL59603A0 (en) 1980-06-30
NZ193077A (en) 1984-05-31

Similar Documents

Publication Publication Date Title
ATE98651T1 (de) Peptide mit tachykininantagonistischer aktivitaet, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
DK149091C (da) Analogifremgangsmaade til fremstilling af peptider indeholdende 2-7 aminosyrerester, desaminodipeptider eller amider deraf med ubiquitin-lignende aktivitet eller farmaceutisk acceptable syreadditionssalte deraf
KR910700062A (ko) 마가이닌 펩타이드의 결실 동족체
ATE2265T1 (de) Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
ATE67406T1 (de) Nicorandil enthaltende zubereitung zum einspritzen.
ES470296A1 (es) Mejoras introducidas en un procedimiento para la preparacionde fluormetal-aminoacidos
ES480112A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
JPS6429347A (en) Amide derivative and external agent for skin containing said derivative
IE781291L (en) Psychopharmacological peptides
ES473090A1 (es) Un procedimiento para la preparacion de l-(piro)glutamil-l- histidil-glicina
NO931091L (no) Analoger av sykloinopeptid a og anvendelse derav
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
IT7921832A0 (it) Farmacologicamente attivi. esteri dell'acido n-(3-trifluorometilfenil)antranilico, procedimento per laloro preparazione e loro preparati
JPS5549361A (en) Novel compound having benzyloxycarbonyl group and its preparation
JPS5661339A (en) Arginine derivative
JPS5484570A (en) Preparation of polypeptide
JPS5583739A (en) Preparation of polypeptide
TH14266B (th) อนุพันธ์เพพไทด์ชนิดใหม่
TH20752A (th) อนุพันธ์เพพไทด์ชนิดใหม่
JPS5359601A (en) Preparation of amino compounds
GB962918A (en) Improvements in or relating to diaralkylamines and salts thereof